Pharmaceutical Management Agency

Response by Pharmaceutical Management Agency to A L.C on September 27, 2024.

Awaiting classification.

Kia ora A L.C Thank you for your request for official information, which Pharmac received on 26 September 2024. The reference number for your request...

Public knowledge of communication

Response by Pharmaceutical Management Agency to A L.C on September 26, 2024.

Awaiting classification.

Kia ora Please find attached a response to your request for official information. Ngā mihi Government Services | Pharmac ______...

Immunosuppressed/diabetic/cancer populations - common associated conditions.

Response by Pharmaceutical Management Agency to J Bruning on May 15, 2024.

Information not held.

Kia ora Jodie, Please find attached a response to your Official Information Act request of 17 April 2024. Thank you Government Services _____________...

Missed time from work considered?

Response by Pharmaceutical Management Agency to PCBS on July 02, 2024.

Awaiting classification.

Kia ora Paul Please find attached a response to your request for official information. Ngā mihi, Government Services | Pharmac 2 Jul...

Decision to delay Pump and CGM Funding for T1 Diabetics

Response by Pharmaceutical Management Agency to Fiona Smith on June 19, 2024.

Awaiting classification.

Kia ora Fiona Please find attached a response to your request for official information. Ngā mihi, Government Services | Pharmac 19 J...

Homonal treatment data

Response by Pharmaceutical Management Agency to Simon Tegg on May 31, 2024.

Successful.

Kia ora, Please find attached a response to your Official Information Act request of 5 May 2024. Thank you Government Services - Pharmac 31 May 2024...

Oestradiol (Estradot) patches, Oestradiol gel and other products

Response by Pharmaceutical Management Agency to M Williams on June 05, 2024.

Awaiting classification.

Kia ora, Please find a response to your Official Information Act request attached. Thank you Government Services - Pharmac 5 June 2024 M Williams V...

Decision not to provide information to Today FM or Mediaworks

Response by Pharmaceutical Management Agency to New Zealand Council for Civil Liberties on February 21, 2023.

Refused.

Tēnā koe Further to our previous communications, we have now published [1]information about our communications approach for the Trikafta consul...

GnRH Agonist statistics

Response by Pharmaceutical Management Agency to Simon Tegg on March 01, 2024.

Successful.

Kia ora Simon Please find a response to your request attached to this email. Ngâ mihi, Katy Carlson (she/her) | Government Services Advisor _______...

Pfizer Contractual Agreement

Response by Pharmaceutical Management Agency to Chuck Schooner (Account suspended) on January 19, 2022.

Long overdue.

Kia ora Chuck Please find a letter in response to your request attached with this email. Ngā mihi Melody Willis ([1]she/her) | Go...

Meeting with New Minister

Response by Pharmaceutical Management Agency to T Murray on January 26, 2024.

Successful.

Kia ora T Murray Please find a response to your request attached to this email. Ngâ mihi, Katy Carlson (she/her) | Government Services Advisor ____...

Maori staff retention

Response by Pharmaceutical Management Agency to TR on June 16, 2023.

Successful.

Tçnâ koe Please find a response to your request for information attached. Ngâ mihi, nâ Melody Willis (she/her) | Government Services Advisor ______...

Meeting with New Minister for Pharmac

Response by Pharmaceutical Management Agency to T Murray on December 12, 2023.

Refused.

Kia ora T Murray Please find a response to your request attached to this email. Ngâ mihi, Katy Carlson (she/her) | Government Services Advisor ____...

MoH criteria for Special Authority application of stimulant medication

Response by Pharmaceutical Management Agency to Cody C on December 11, 2023.

Information not held.

Kia ora Cody Please find a response to your request attached to this email. Ngâ mihi, Katy Carlson (she/her) | Government Services Advisor ________...

OIA publication

Response by Pharmaceutical Management Agency to Rex Davey on November 22, 2023.

Awaiting classification.

Kia ora Rex, Please find a response to your OIA request attached. Ngā mihi Pharmac Government Services Team 22 November 2023 Rex Davey Via email:...

Covid19 XBB Vaccine availability

Response by Pharmaceutical Management Agency to Daniel Richards on September 19, 2023.

Awaiting classification.

Kia ora Daniel Please find a response to your request attached to this email. Ngâ mihi, Katy Carlson ([1]she/her) | Government Se...

Information regarding medicinal cannabis prescriptions

Response by Pharmaceutical Management Agency to Mr McDonald on June 14, 2023.

Information not held.

Kia ora Mr McDonald, Please find a response to your request attached to this email. Kind regards, Gendi McFadyen| Government Services Advisor Te Pāt...

Estimating the number of people prescribed PrEP

Response by Pharmaceutical Management Agency to Bianca Sepulveda on June 11, 2021.

Successful.

Kia ora Bianca Please find attached a response to your recent request for information. Ngā mihi Melody Willis ([1]she/her) | Gove...

Trikafta Funding Announcement

Response by Pharmaceutical Management Agency to Phillip Hart on February 21, 2023.

Partially successful.

Tçnâ koe Phillip Further to our previous communications, we have now published [1]information about our communications approach for the Trikafta...

Correspondence between Pharmac and Draper Cormack re 2022-23-125; A1665003

Response by Pharmaceutical Management Agency to Harris Leigh on April 28, 2023.

Successful.

Tēnā koe Harris Please find a response to your request for information attached with this email. Ngā mihi, nā Melody Willis ([1]...

All emails from the Chief Executive, Director of Operations and communications staff in 2022 mentioning continuous glucose monitors

Response by Pharmaceutical Management Agency to Stefan Clausing on March 30, 2023.

Awaiting classification.

Kia ora Stefan, Please find a response to your request attached to this email. Kind regards Gendi McFadyen| Government Services Advisor Te Pātaka Wh...

Procurement process for Cormack Draper

Response by Pharmaceutical Management Agency to Harris Leigh on March 28, 2023.

Partially successful.

Tçnâ koe Harris Please find a response to your below request for information attached to this email. Ngâ mihi, nâ Melody Willis...

Funding for Ixekizumab

Response by Pharmaceutical Management Agency to Ms Faulkner on March 21, 2023.

Awaiting classification.

Kia ora Ms Faulkner, Please find a response to your request attached to this email. Kind regards, Gendi McFadyen| Government Services Advisor Te Pāt...

Rolling reviews of safety & efficacy of (non-mRNA gene therapy) COVID-19 treatments

Response by Pharmaceutical Management Agency to J Bruning on January 17, 2023.

Successful.

Kia ora Please find a response to your request for information attached with this email. Ngā mihi Melody Willis (she/her) | Government Services Adv...

Correspondence between Pharmac and NZMS

Request to Pharmaceutical Management Agency by D Smith. Annotated by Jai Ganesh on December 17, 2022.

Awaiting classification.

Sooo Medsafe knew that Ivermectin was a safe and effective treatment but because a pharmaceutical company didn't apply to push it out because it's not...

FYI

More about this authority